Found: 15
Select item for more details and to access through your institution.
Selection Criteria for Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy With Special Emphasis on Laparoscopy as an Efficient Tool.
- Published in:
- In Vivo, 2022, v. 36, n. 3, p. 1367, doi. 10.21873/invivo.12840
- By:
- Publication type:
- Article
Extraperitoneal Approach During Peritonectomy in the Right Upper Quadrant for Peritoneal Metastases from Ovarian Malignancies.
- Published in:
- In Vivo, 2022, v. 36, n. 1, p. 341, doi. 10.21873/invivo.12708
- By:
- Publication type:
- Article
Malignant Struma Ovarii Τreated With Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC).
- Published in:
- In Vivo, 2021, v. 35, n. 6, p. 3591, doi. 10.21873/invivo.12664
- By:
- Publication type:
- Article
Prognostic Factors in Pseudomyxoma Peritonei with Emphasis on the Predictive Role of Peritoneal Cancer Index and Tumor Markers.
- Published in:
- Cancers, 2023, v. 15, n. 4, p. 1326, doi. 10.3390/cancers15041326
- By:
- Publication type:
- Article
Role of HIPEC after Complete Cytoreductive Surgery (CRS) in Peritoneal Recurrence of Platinum-Sensitive Recurrent Ovarian Cancer (OC): The Aim for Standardization at Two Reference Centers for CRS.
- Published in:
- Cancers, 2023, v. 15, n. 2, p. 405, doi. 10.3390/cancers15020405
- By:
- Publication type:
- Article
Patients with Metachronous Peritoneal Metastatic Mucinous Colorectal Adenocarcinoma Benefit More from Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) than Their Synchronous Counterparts.
- Published in:
- Cancers, 2022, v. 14, n. 16, p. 3978, doi. 10.3390/cancers14163978
- By:
- Publication type:
- Article
Prolonged Exposition with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) May Provide Survival Benefit after Cytoreductive Surgery (CRS) in Advanced Primary Epithelial Ovarian, Fallopian Tube, and Primary Peritoneal Cancer.
- Published in:
- Cancers, 2022, v. 14, n. 14, p. N.PAG, doi. 10.3390/cancers14143301
- By:
- Publication type:
- Article
The Characteristics of 206 Long-Term Survivors with Peritoneal Metastases from Colorectal Cancer Treated with Curative Intent Surgery: A Multi-Center Cohort from PSOGI.
- Published in:
- Cancers, 2021, v. 13, n. 12, p. 2964, doi. 10.3390/cancers13122964
- By:
- Publication type:
- Article
Ten-year single-center experience with treatment of primary diffuse malignant peritoneal mesothelioma (DMPM) by cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC).
- Published in:
- Langenbeck's Archives of Surgery, 2022, v. 407, n. 7, p. 3057, doi. 10.1007/s00423-022-02594-6
- By:
- Publication type:
- Article
Early postoperative CRP predicts major complications following cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC).
- Published in:
- Pleura & Peritoneum, 2023, v. 8, n. 3, p. 113, doi. 10.1515/pp-2022-0203
- By:
- Publication type:
- Article
Reduction of Postoperative Complications in Pancreatic Surgery by Standardizing Perioperative Management: An Observational Cohort Study.
- Published in:
- Visceral Medicine, 2024, v. 40, n. 4, p. 184, doi. 10.1159/000539688
- By:
- Publication type:
- Article
Current clinical practices of cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC).
- Published in:
- Innovative Surgical Sciences, 2024, v. 9, n. 1, p. 3, doi. 10.1515/iss-2023-0055
- By:
- Publication type:
- Article
Peritoneal Metastatic Gastric Cancer: Local Treatment Options and Recommendations.
- Published in:
- Current Oncology, 2024, v. 31, n. 3, p. 1445, doi. 10.3390/curroncol31030109
- By:
- Publication type:
- Article
Survival Difference of Endometrial Cancer Patients with Peritoneal Metastasis Receiving Cytoreductive Surgery (CRS) with and without Hyperthermic Intraperitoneal Chemotherapy (HIPEC): A Systematic Review and Meta-Analysis.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 13, p. 7495, doi. 10.3390/ijms25137495
- By:
- Publication type:
- Article
High Tumor-Infiltrating Lymphocyte Count Is Associated with Distinct Gene Expression Profile and Longer Patient Survival in Advanced Ovarian Cancer.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 18, p. 13684, doi. 10.3390/ijms241813684
- By:
- Publication type:
- Article